 (1).png)
The logo of the pharmaceutical company Bristol-Myers Squibb, (BMS) is seen on the facade of the company's Munich headquarters on August 29, 2024 in Munich
(Bavaria).
Matthias Balk | Picture Alliance | Getty Images
JPMorgan touts Bristol Myers Squibb as a top biopharma pick. Jim Cramer is also quite fond of it.
English (US) ·